Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
Abroad (travel likely)Recruiting
Conditions
Myeloproliferative Neoplasm · Essential Thrombocythemia · Primary Myelofibrosis, Prefibrotic Stage · Primary Myelofibrosis, Fibrotic Stage
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Angers, Angers, France
Contact: Study coordinator (Laurane COTTIN, Dr)Chu Bordeaux, Bordeaux, France
Contact: Study coordinator (Olivier MANSIER, DOCTOR) · olivier.mansier@u-bordeaux.fr · +335 57 65 64 78Chu Brest, Brest, France
Ch Cholet, Cholet, France
Contact: Study coordinator (CHARLES BESCOND, DOCTOR) · alain.zannetti@ch-cholet.fr · +332 41 49 68 07Ch Le Mans, Le Mans, France
Ch Morlaix, Morlaix, France
AP-HP Henri Mondor, Paris, France
Chu Poitiers, Poitiers, France
Contact: Study coordinator (Jose Miguel TORREGROSA-DIAZ, DOCTOR) · jose-miguel.torregrosa-diaz@inserm.eu · +335 49 44 44 44Ch Quimper, Quimper, France
Contact: Study coordinator (Lenaig LE CLECH, DOCTOR) · l.leclech@ch-cornouaille.fr · +332 98 52 61 50Chu Tours, Tours, France
Contact: Study coordinator (Olivier HERAULT, PROFESSOR) · olivier.herault@univ-tours.fr · +332 47 47 47 21